We are monitoring the impact of COVID-19 on MEA Bioabsorbable Stents Market Get in touch with us for detailed analysis Know More
Share on

Middle East & Africa Bioabsorbable Stents Market Research Report – Segmented By Material, Absorption, Application, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2022 to 2027)

Published: January, 2022
ID: 2082
Pages: 145

MEA Bioabsorbable Stents Market Size & Growth (2022 to 2027)

The size of the bioabsorbable stents market in the Middle East and Africa is expected to grow USD 527.04 billion by 2027 from USD 89.29 billion in 2022 at a CAGR of 42.63% during the forecast period.

Clinical research has demonstrated that resorbable platforms, or normally dissolving stents, offer practically identical safety and efficacy profile to medicate stents. In particular, the stent has been examined in single-arm trials and in randomized trials comparing it with a Drug-eluting stent (DES).

Imaging tests show that the absorb dissolving stent starts to break down from 6 to 12 months and is completely broken up in the middle of a few years after it is set in the supply route. Two little platinum markers stay to check the area of the first PCI. The supply route can enlarge and contract, called vasomotion, like a solid vein at two years.

Increment in cardiovascular surgeries is due to a rise in the danger of cardiovascular issues among the people suffering from obesity. As per WHO reports, cardiovascular problems are the main source of death than any other health issues, it is expected that by 2030 more than 23 million individuals may die due to Cardiovascular diseases. Thus, the aging population and an increase in cardiovascular diseases are the key driving factors for the growth of the market. Positive outcomes of surgeries with bioabsorbable stents and post-surgery reports also account for the development of the market.

However, there are many regulatory, technological, safety-efficacy and also cost-related issues that the market has to deal with before reaching its full potential.

This research report on the MEA Bioabsorbable Stents Market has been segmented and sub-segmented into the following categories.

By Material:

  • Polymer Stents
  • Metallic Stents

By Absorption Rate:

  • Slow Absorption Rate Stents
  • High Absorption Rate Stents

By Application:

  • Coronary Artery Disease
  • Peripheral Artery Disease

By End User:

  • Hospitals
  • Cardiac Centers

By Country:

  • KSA
  • UAE
  •  Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Companies dominating the MEA Bioabsorbable stents market are Elixir Medical Corporation, Arterius Limited, Amaranth Medical Inc, Abbott Laboratories, Arterial Remodeling Technologies S.A, Biotronik, Kyoto Medical Planning Co Ltd., Reva Medical Inc, Tepha.Inc, SMT, Xenogenics Corporation

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Material                       

                                5.1.1 Introduction           

                                5.1.2 Polymer stents      

                                5.1.3 Metallic stents       

                                5.1.4  Y-o-Y Growth Analysis, By Material             

                                5.1.5  Market Attractiveness Analysis, By Material           

                                5.1.6  Market Share Analysis, By Material             

                5.2 Absorption                 

                                5.2.1 Introduction           

                                5.2.2 Slow absorption stents      

                                5.2.3 High absorption stents       

                                5.2.4 Y-o-Y Growth Analysis, By absorption         

                                5.2.5 Market Attractiveness Analysis, By absorption       

                                5.2.6 Market Share Analysis, By absorption         

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 coronary artery disease     

                                5.3.3 peripheral artery disease  

                                5.3.7 Y-o-Y Growth Analysis, By Application         

                                5.3.8  Market Attractiveness Analysis, By Application      

                                5.3.9  Market Share Analysis, By Application       

                5.4 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospitals  

                                5.4.3 Cardiac centers     

                                5.4.7 Y-o-Y Growth Analysis, By End User             

                                5.4.8  Market Attractiveness Analysis, By End User          

                                5.4.9  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Material

                                                6.1.3.3 By absorption

                                                6.1.3.4 By Application

                                                6.1.3.5 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Material

                                                6.1.4.3 By absorption

                                                6.1.4.4 By Application

                                                6.1.4.5 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Material

                                                6.1.5.3 By Absorption

                                                6.1.5.4 By Application

                                                6.1.5.5 By End User

                6.2 Middle East & Africa                               

                                6.2.1 Introduction           

                                6.2.2 Middle-East            

                                6.2.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Elixir Medical Corporation                    

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Arterius Limited                        

                8.3 Amaranth Medical Inc                            

                8.4 Abbott Laboratories                               

                8.5  Arterial Remodeling Technologies S.A                           

                8.6  Biotronik                     

                8.7  Kyoto Medical Planning Co Ltd                          

                8.8  Reva Medical Inc                     

                8.9 Tepha.Inc                    

                8.10 Xenogenics Corporation                     

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures           

MEA Bioabsorbable Stents Market

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample